(BLX) Foreign Trade Bank of Latin - Ratings and Ratios
Trade Finance, Syndicated Credits, Letters Of Credit, Guarantees, Leasing
EPS (Earnings per Share)
Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 25.3% |
| Value at Risk 5%th | 39.4% |
| Relative Tail Risk | -5.34% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.16 |
| Alpha | 22.47 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.574 |
| Beta | 0.772 |
| Beta Downside | 0.884 |
| Drawdowns 3y | |
|---|---|
| Max DD | 21.01% |
| Mean DD | 4.08% |
| Median DD | 3.09% |
Description: BLX Foreign Trade Bank of Latin November 13, 2025
Banco Latinoamericano de Comercio Exterior (BLX) is a Panama-based multinational bank that finances foreign trade and economic integration across Latin America and the Caribbean. It operates two primary segments-Commercial and Treasury-accepts deposits, and provides a suite of credit products including bilateral loans, syndicated facilities, letters of credit, factoring, vendor financing, and leasing, as well as investment-management services.
Key data points to watch: (1) BLX’s loan-to-deposit ratio has hovered around 85% in the last twelve months, indicating a balanced funding profile; (2) its exposure to commodity-linked trade finance means earnings are sensitive to regional export volumes, which have risen ~4% YoY in 2024 amid higher demand for agricultural products; and (3) the bank’s return on equity (ROE) has stabilized near 12% after a 2023 dip, reflecting improving asset quality and tighter risk controls.
For a deeper quantitative view, the ValueRay platform offers a granular breakdown of BLX’s risk-adjusted returns and peer comparisons.
BLX Stock Overview
| Market Cap in USD | 1,641m |
| Sub-Industry | Specialized Finance |
| IPO / Inception | 1992-09-24 |
| Return 12m vs S&P 500 | 21.9% |
| Analyst Rating | 4.50 of 5 |
BLX Dividends
| Metric | Value |
|---|---|
| Dividend Yield | 5.70% |
| Yield on Cost 5y | 22.98% |
| Yield CAGR 5y | 15.21% |
| Payout Consistency | 81.9% |
| Payout Ratio | 41.6% |
BLX Growth Ratios
| Metric | Value |
|---|---|
| CAGR 3y | 47.80% |
| CAGR/Max DD Calmar Ratio | 2.28 |
| CAGR/Mean DD Pain Ratio | 11.70 |
| Current Volume | 161.2k |
| Average Volume | 118.5k |
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income (222.4m TTM) > 0 and > 6% of Revenue (6% = 41.5m TTM) |
| FCFTA 0.01 (>2.0%) and ΔFCFTA 1.76pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -754.5% (prev -598.9%; Δ -155.6pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.01 (>3.0%) and CFO 143.3m <= Net Income 222.4m (YES >=105%, WARN >=100%) |
| Net Debt (3.56b) to EBITDA (225.1m) ratio: 15.79 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.30 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (37.2m) change vs 12m ago 1.21% (target <= -2.0% for YES) |
| Gross Margin 43.36% (prev 50.57%; Δ -7.22pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 5.78% (prev 7.24%; Δ -1.46pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.44 (EBITDA TTM 225.1m / Interest Expense TTM 381.3m) >= 6 (WARN >= 3) |
Altman Z'' -2.25
| (A) -0.42 = (Total Current Assets 2.19b - Total Current Liabilities 7.40b) / Total Assets 12.50b |
| (B) 0.07 = Retained Earnings (Balance) 891.3m / Total Assets 12.50b |
| (C) 0.01 = EBIT TTM 167.4m / Avg Total Assets 11.95b |
| (D) 0.15 = Book Value of Equity 1.62b / Total Liabilities 10.85b |
| Total Rating: -2.25 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 57.31
| 1. Piotroski 2.0pt = -3.0 |
| 2. FCF Yield 4.47% = 2.24 |
| 3. FCF Margin 20.27% = 5.07 |
| 4. Debt/Equity 2.16 = 0.53 |
| 5. Debt/Ebitda 15.79 = -2.50 |
| 6. ROIC - WACC (= -2.28)% = -2.86 |
| 7. RoE 15.42% = 1.28 |
| 8. Rev. Trend 27.60% = 2.07 |
| 9. EPS Trend 89.60% = 4.48 |
What is the price of BLX shares?
Over the past week, the price has changed by -0.59%, over one month by -1.72%, over three months by -1.26% and over the past year by +38.50%.
Is BLX a buy, sell or hold?
- Strong Buy: 1
- Buy: 1
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the BLX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 55.5 | 26.6% |
| Analysts Target Price | 55.5 | 26.6% |
| ValueRay Target Price | 65.5 | 49.5% |
BLX Fundamental Data Overview November 11, 2025
P/E Trailing = 7.4333
P/S = 5.3201
P/B = 1.1836
P/EG = 1.58
Beta = 0.843
Revenue TTM = 691.3m USD
EBIT TTM = 167.4m USD
EBITDA TTM = 225.1m USD
Long Term Debt = 2.70b USD (from longTermDebt, last fiscal year)
Short Term Debt = 139.4m USD (from shortTermDebt, last quarter)
Debt = 3.56b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.56b USD (from netDebt column, last quarter)
Enterprise Value = 3.13b USD (1.64b + Debt 3.56b - CCE 2.06b)
Interest Coverage Ratio = 0.44 (Ebit TTM 167.4m / Interest Expense TTM 381.3m)
FCF Yield = 4.47% (FCF TTM 140.1m / Enterprise Value 3.13b)
FCF Margin = 20.27% (FCF TTM 140.1m / Revenue TTM 691.3m)
Net Margin = 32.18% (Net Income TTM 222.4m / Revenue TTM 691.3m)
Gross Margin = 43.36% ((Revenue TTM 691.3m - Cost of Revenue TTM 391.6m) / Revenue TTM)
Gross Margin QoQ = 100.0% (prev 39.23%)
Tobins Q-Ratio = 0.25 (Enterprise Value 3.13b / Total Assets 12.50b)
Interest Expense / Debt = 3.56% (Interest Expense 126.7m / Debt 3.56b)
Taxrate = 21.0% (US default 21%)
NOPAT = 132.3m (EBIT 167.4m * (1 - 21.00%))
Current Ratio = 0.30 (Total Current Assets 2.19b / Total Current Liabilities 7.40b)
Debt / Equity = 2.16 (Debt 3.56b / totalStockholderEquity, last quarter 1.65b)
Debt / EBITDA = 15.79 (Net Debt 3.56b / EBITDA 225.1m)
Debt / FCF = 25.38 (Net Debt 3.56b / FCF TTM 140.1m)
Total Stockholder Equity = 1.44b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.78% (Net Income 222.4m / Total Assets 12.50b)
RoE = 15.42% (Net Income TTM 222.4m / Total Stockholder Equity 1.44b)
RoCE = 4.04% (EBIT 167.4m / Capital Employed (Equity 1.44b + L.T.Debt 2.70b))
RoIC = 2.44% (NOPAT 132.3m / Invested Capital 5.42b)
WACC = 4.72% (E(1.64b)/V(5.20b) * Re(8.86%) + D(3.56b)/V(5.20b) * Rd(3.56%) * (1-Tc(0.21)))
Discount Rate = 8.86% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.94%
[DCF Debug] Terminal Value 66.85% ; FCFE base≈140.1m ; Y1≈92.0m ; Y5≈42.1m
Fair Price DCF = 25.18 (DCF Value 723.5m / Shares Outstanding 28.7m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 89.60 | EPS CAGR: 22.23% | SUE: 4.0 | # QB: 5
Revenue Correlation: 27.60 | Revenue CAGR: 17.26% | SUE: 4.0 | # QB: 9
Additional Sources for BLX Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle